Jami Taylor

Jami Taylor, MBA, IRC, serves on the Board of Directors at Aneira Pharma, Inc. since November 2021 and holds a position as an Advisory Board Member for Health Innovation Exchange since March 2022. Taylor has been a guest lecturer at numerous prestigious universities, including MIT Sloan, Yale, Northwestern, Harvard, Tufts, Georgetown, and Wharton since 2013, and has served as a subject-matter expert advisor at the Duke-Margolis Center for Health Policy. In recent roles, Taylor was Vice President and Head of Investor Relations at Coherus BioSciences (November 2023 - January 2024) and Vice President of Corporate Affairs at Protagonist Therapeutics (March 2021 - November 2023), where significant contributions were made during pivotal transitions in the company's development. Prior experience includes leadership roles in Corporate Affairs at Johnson & Johnson from July 2007 to June 2018, with a focus on global public health and strategic partnerships. Jami Taylor holds multiple advanced degrees, including an MBA from Northwestern University and a Master's degree from Harvard University.